Deepverge PLC DeepVerge Investor Presentation
March 25 2021 - 11:43AM
RNS Non-Regulatory
TIDMDVRG
Deepverge PLC
25 March 2021
25 Mar 2021
DeepVerge PLC
("DeepVerge" or "Company")
DeepVerge Investor Presentation
Project Updates on Labskin, Modern Water, Skin Trust Club and
Microsaic Agreement
DeepVerge (LSE:DVRG.L), the environmental and life science AI
company , announces that, DeepVerge (LSE:DVRG.L), the environmental
and life science AI company , announces that, is pleased to
announce that Gerry Brandon, CEO will provide a live presentation
relating to Project Updates - Labskin, Skin Trust Club, Modern
Water - Wastewater & Breath Test via the Investor Meet Company
platform on 31st Mar 2021 at 1:30pm BST.
The presentation is open to all existing and potential
shareholders. Questions can be submitted pre-event via your
Investor Meet Company dashboard up until 9am the day before the
meeting or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add
to meet DEEPVERGE PLC via:
https://www.investormeetcompany.com/deepverge-plc/register-investor
Investors who already follow DEEPVERGE PLC on the Investor Meet
Company platform will automatically be invited.
+44 (0) 734 0055
DeepVerge plc Gerry Brandon 648
SPARK Advisory Partners
Limited Neil Baldwin/Andrew +44 (0) 113 370
(Nominated Adviser) Emmott 8974
Turner Pope Investments Andy Thacker/Zoe +44 (0) 20 3657
(TPI) Limited (Broker) Alexander 0050
About DeepVerge plc (www.deepverge.com)
DeepVerge is an environmental and life science group of
companies that develops and applies AI and IoT technology to
analytical instruments and the data they generate, for the analysis
and identification of bacteria, virus and toxins. DeepVerge is
utilising artificial intelligent data analytics to prove
scientifically the impact of skincare product claims on the skin
microbiome for clients including most of the top 20 global cosmetic
companies and to detect remotely, and identify in real-time,
dangerous pathogens in wastewater treatment plants, drinking water,
rivers, lakes and reservoirs.
About Microsaic (www.microsaic.com)
Microsaic floated on AIM in 2011 to develop and commercialise
micro-engineering chip-based mass spectrometry equipment. Having
invested c.GBP30m over 20 years of development, Microsaic has a
robust and innovative patent portfolio in cutting-edge technology
designed and developed for "Industry 4.0" application. Microsaic
serves markets in Human Health, Environmental Health and
Diversified Industries. Microsaic's system solutions enable
analytical detection and characterisation at the point-of-need,
whether within a conventional laboratory setting, or within a
bioprocessing facility for continuous mass spectrometer detection
data at multiple steps in the process workflow.
Microsaic's products and systems are commercially available
through global markets via a network of regional and local
partners, targeting its core laboratory, manufacturing and point of
need applications.
About Reach announcements
Reach is an investor communication service aimed at assisting
listed and unlisted (including AIM quoted) companies to distribute
media only / non-regulatory news releases such as marketing
messages, corporate and product information into the public domain.
An RNS Regulatory announcement is required to be notified under the
AIM Rules for Companies.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAEELFLFXLZBBL
(END) Dow Jones Newswires
March 25, 2021 11:43 ET (15:43 GMT)
Integumen (LSE:SKIN)
Historical Stock Chart
From Apr 2024 to May 2024
Integumen (LSE:SKIN)
Historical Stock Chart
From May 2023 to May 2024